Understand the source comparison
Half-Life Comparison
The half-life difference between the two analogs is striking: IGF-1 LR3: Estimated half-life of ~20–30 hours in biological systems IGF-1 DES: Estimated half-life of ~20–30 minutes — substantially longer than free native IGF-1 (~10–20 min), but far shorter than
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The half-life difference between the two analogs is striking:
- IGF-1 LR3: Estimated half-life of ~20–30 hours in biological systems
- IGF-1 DES: Estimated half-life of ~20–30 minutes — substantially longer than free native IGF-1 (~10–20 min), but far shorter than IGF-1 LR3
- This difference directly impacts how experiments must be structured. Studies using IGF-1 DES in cell culture require more frequent compound replenishment to maintain receptor activation over multi-day windows. For in vivo models, more frequent administration intervals are needed to maintain sustained receptor engagement with DES compared to LR3.
- The extended half-life of IGF-1 LR3 is directly attributable to its superior IGFBP resistance — less sequestration means the peptide persists in circulation longer. A detailed analysis is available in: IGF-1 LR3 Research Peptide Half-Life and Stability Advantages for Long-Term Lab Studies.